EICHORCondition: Oral Squamous Cell Carcinoma (OSCC) · Sponsor: Memorial Sloan Kettering Cancer Center
The purpose of this study is to test if an investigational dye, called PARPi-FL, can be used to detect this type of cancer. This will be the first time that PARPi-FL is being tried in people. First, the investigators will test the safety of PARPi-FL at different doses to find out what effects, if any, it has on people. The investigators will also see which amount of PARPi-FL is best suited to detect cancers of the mouth and tongue.
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
| Memorial Sloan Kettering Basking Ridge (Consent Only) | Basking Ridge, New Jersey, United States | — |
| Memorial Sloan Kettering Monmouth (Consent only) | Middletown, New Jersey, United States | — |
| Memorial Sloan Kettering Bergen (Consent only) | Montvale, New Jersey, United States | — |
| Memorial Sloan Kettering Suffolk-Commack (Consent only) | Commack, New York, United States | — |
| Memorial Sloan Kettering Westchester (Consent Only) | Harrison, New York, United States | — |
| Memorial Sloan Kettering Cancer Center | New York, New York, United States | — |
| Memorial Sloan Kettering Nassau (Consent only) | Rockville Centre, New York, United States | — |
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03085147